171 related articles for article (PubMed ID: 35962514)
1. Intralesional immunotherapy for non-genital warts: A systematic review and meta-analysis.
Ju HJ; Park HR; Kim JY; Kim GM; Bae JM; Lee JH
Indian J Dermatol Venereol Leprol; 2022; 88(6):724-737. PubMed ID: 35962514
[TBL] [Abstract][Full Text] [Related]
2. Intralesional immunotherapy for pediatric warts: A review.
Fields JR; Saikaly SK; Schoch JJ
Pediatr Dermatol; 2020 Mar; 37(2):265-271. PubMed ID: 31930595
[TBL] [Abstract][Full Text] [Related]
3. A review of intralesional wart therapy.
Muse ME; Stiff KM; Glines KR; Cline A; Feldman SR
Dermatol Online J; 2020 Mar; 26(3):. PubMed ID: 32609439
[TBL] [Abstract][Full Text] [Related]
4. Intralesional measles, mumps, and rubella vaccine after failure of intralesional Candida antigen for the treatment of recalcitrant pediatric warts.
Ulschmid CM; Patel J; Pan AY; Liegl M; Holland KE
Pediatr Dermatol; 2023; 40(6):1057-1059. PubMed ID: 37596908
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of Intralesional
Zayan H; Hosny AH; Mamdouh MM; Tawfik YM
J Cutan Med Surg; 2024; 28(3):253-258. PubMed ID: 38497287
[TBL] [Abstract][Full Text] [Related]
6. Intralesional Measles, Mumps, and Rubella Vaccine Versus Intralesional
Nofal A; El-Arab RE; Nasr M; Alakad R
J Cutan Med Surg; 2021; 25(4):377-383. PubMed ID: 33533654
[TBL] [Abstract][Full Text] [Related]
7. Intralesional antigen immunotherapy for the treatment of plane warts: A comparative study.
Fawzy MM; Nofal A; Alakad R
Dermatol Ther; 2020 Nov; 33(6):e13807. PubMed ID: 32530550
[TBL] [Abstract][Full Text] [Related]
8. Comparative study between intralesional injection of MMR, BCG, and candida albicans antigen in treatment of multiple recalcitrant warts.
Eldahshan RM; Ashry WMO; Elsaie ML
J Cosmet Dermatol; 2022 Mar; 21(3):1120-1126. PubMed ID: 34998000
[TBL] [Abstract][Full Text] [Related]
9. Intralesional Antigen Immunotherapy in the Treatment of Periungual Warts.
Nofal A; Alakad R; Fouda I; Fawzy MM
J Cutan Med Surg; 2021; 25(3):286-292. PubMed ID: 33504211
[TBL] [Abstract][Full Text] [Related]
10. Intralesional Measles-Mumps-Rubella Vaccine for Genital Warts: Report of two cases with a review of literature.
Al-Qassabi AM; Al-Farsi F
Sultan Qaboos Univ Med J; 2022 Aug; 22(3):413-416. PubMed ID: 36072081
[TBL] [Abstract][Full Text] [Related]
11. A comparative study of the efficacy and safety of intralesional measles, mumps, and rubella vaccine versus intralesional vitamin D3 for the treatment of warts in children.
Mohta A; Kushwaha RK; Gautam U; Sharma P; Nyati A; Jain SK
Pediatr Dermatol; 2020 Sep; 37(5):853-859. PubMed ID: 32681688
[TBL] [Abstract][Full Text] [Related]
12. Intralesional immunotherapy for multiple recalcitrant plantar warts: Candida antigen is superior to intralesional purified protein derivative.
Nofal A; Adel L; Fawzy M; Elkholy BM
Dermatol Ther; 2022 Jun; 35(6):e15440. PubMed ID: 35285995
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of intralesional immunotherapy for the treatment of warts: A review of the literature.
Aldahan AS; Mlacker S; Shah VV; Kamath P; Alsaidan M; Samarkandy S; Nouri K
Dermatol Ther; 2016 May; 29(3):197-207. PubMed ID: 26991521
[TBL] [Abstract][Full Text] [Related]
14. Intralesional Measles, Mumps, Rubella Vaccine versus Tuberculin Purified Protein Derivative Injections in the Treatment of Palmoplantar and Periungual Warts: A Double-Blind Randomized Controlled Trial.
Rutnin S; Namasondhi A; Pomsoong C; Kositkuljorn C; Anuntrangsee T; Thadanipon K
Dermatology; 2023; 239(1):109-115. PubMed ID: 36282051
[TBL] [Abstract][Full Text] [Related]
15. Treatment of recalcitrant warts with intralesional measles, mumps, and rubella vaccine: a promising approach.
Nofal A; Nofal E; Yosef A; Nofal H
Int J Dermatol; 2015 Jun; 54(6):667-71. PubMed ID: 25070525
[TBL] [Abstract][Full Text] [Related]
16. Comparative study of intralesional tuberculin protein purified derivative (PPD) and intralesional measles, mumps, rubella (MMR) vaccine for multiple resistant warts.
Mohammed YF; Ibrahim HS; Elbarbary MA; Elsaie ML
J Cosmet Dermatol; 2021 Mar; 20(3):868-874. PubMed ID: 33118675
[TBL] [Abstract][Full Text] [Related]
17. Intralesional injection of purified protein derivative versus Candida antigen in treatment of genital warts.
Tawfik NZ; Eyada MMK; Abdel El Hamid RE; Halim HM
Dermatol Ther; 2022 Oct; 35(10):e15762. PubMed ID: 36056784
[TBL] [Abstract][Full Text] [Related]
18. Immunotherapy in viral warts with intradermal
Podder I; Bhattacharya S; Mishra V; Sarkar TK; Chandra S; Sil A; Pal S; Kumar D; Saha A; Shome K; Bandyopadhyay D; Das NK
Indian J Dermatol Venereol Leprol; 2017; 83(3):411. PubMed ID: 27852999
[TBL] [Abstract][Full Text] [Related]
19. Intralesional tuberculin (PPD) versus measles, mumps, rubella (MMR) vaccine in treatment of multiple warts: a comparative clinical and immunological study.
Shaheen MA; Salem SA; Fouad DA; El-Fatah AA
Dermatol Ther; 2015; 28(4):194-200. PubMed ID: 25847793
[TBL] [Abstract][Full Text] [Related]
20. Intralesional immunotherapy for the treatment of anogenital warts in pediatric population.
Nofal A; Alakad R
J Dermatolog Treat; 2022 Mar; 33(2):1042-1046. PubMed ID: 32703042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
